Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04769453 · ClinicalTrials.gov registry record · NA
Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty
A NA study, sponsored by Nova Eye.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04769453: Clinical Trial NA study, sponsored by Nova Eye.
NCT04769453 is a NA study that was terminated before completion, run by Nova Eye. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04769453, a NA study, was terminated before completion, sponsored by Nova Eye.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (OVD).
Primary Outcome
IOP will be measured at each study visit using Goldmann applanation tonometry
Interventions
- DEVICE Canaloplasty using the iTrack microcatheter with Healon GV Pro
- DEVICE Canaloplasty using the Omni surgical system with Healon GV Pro
- DEVICE Canaloplasty using the iTrack microcatheter with Healon Pro
- DEVICE Canaloplasty using the Omni surgical system with Healon Pro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-04-29 |
| Est. Completion | 2023-01-26 |
| Phase | NA |
Why NCT04769453 stopped before completion
NCT04769453 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Canaloplasty using the iTrack microcatheter with Healon GV Pro is the first listed.
NCT04769453 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04769453 about?
NCT04769453 is a clinical study titled "Multicenter Ab-interno Glaucoma Study Investigating Canaloplasty". A prospective, multicenter, randomized, single-masked clinical trial to evaluate the effectiveness outcomes of canaloplasty performed as a standalone procedure with the iTrack microcatheter to the Omni surgical system, and to compare the effectiveness of two types of Ophthalmic Viscoelastic Device (...
What is the current status of trial NCT04769453?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2021-04-29. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT04769453?
The interventions under investigation include: Canaloplasty using the iTrack microcatheter with Healon GV Pro (DEVICE), Canaloplasty using the Omni surgical system with Healon GV Pro (DEVICE), Canaloplasty using the iTrack microcatheter with Healon Pro (DEVICE), Canaloplasty using the Omni surgical system with Healon Pro (DEVICE).
Who is sponsoring clinical trial NCT04769453?
This trial is sponsored by Nova Eye, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04769453's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI